Posted:
10/17/2024, 5:00:00 PM
Location(s):
Bothell, Washington, United States ⋅ Florida, United States ⋅ New York, New York, United States ⋅ Connecticut, United States ⋅ Massachusetts, United States ⋅ California, United States ⋅ Groton, Connecticut, United States ⋅ Louisiana, United States ⋅ Tampa, Florida, United States ⋅ Washington, United States ⋅ Cambridge, Massachusetts, United States ⋅ New York, United States
Experience Level(s):
Senior
Field(s):
Finance & Banking
Workplace Type:
Remote
This role, Sr Manager Finance - Pfizer Oncology Division (POD), provides a unique opportunity to serve as a strategic financial partner to certain Partner Line leads in the Pfizer Oncology Division (POD), which reports into Chris Boshoff and leads support efforts from discovery to early and late‑phase clinical development. The Oncology Leadership Team members the team supports includes Clinical Development & Operations (CD&O), Late and Early-Stage Development, CLIN Pharm, Scientific Affairs and Strategic Partnerships, Oncology Research Unit and Executive Operations. This position will provide financial, operational and strategic leadership support to the role’s leadership teams in a complex and very dynamic environment to optimize budget allocation and maximize the value of the portfolio. He / She operates in a very matrix environment with multiple stakeholders across different finance and R&D groups. Through insightful understanding of the pharma business, rigorous review and partnership with Partner Line Leaders, the Sr Manager Finance is responsible for providing financial advice and guidance on key business decisions, delivery of financial commitments and ensuring optimal deployment of capital.
ROLE RESPONSIBILITIES
Provides financial support for a number of R&D Partner Line leads in the Pfizer Oncology Division (POD). Responsibilities include:
REQUIRED BASIC QUALIFICATIONS
PREFERRED QUALIFICATIONS
Other job details
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Website: https://www.pfizer.com/
Headquarter Location: New York, New York, United States
Employee Count: 10001+
Year Founded: 1849
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine